Panacea Biotech Ltd has fixed February 11 as record date for the purpose of stock split of existing equity shares- from every one existing equity share of Rs 10 each into ten equity shares of Re 1 each.\n\n\n\n
Global pharma and biotech companies, especially those from US, Europe and Japan, are keen to sign agreements with Indian companies, according to experts.
Renuka Ramnath is credited with raising the India Advantage Fund Series II, the country's largest private equity fund till date with a corpus of $810 million.
Addressing an industry meet in Bangalore, Rajashekar Reddy said infrastructure in Andhra Pradesh was better than any other state in the country.
Infosys CEO Kris Gopalkrishnan says his company is in regular touch with the state government regarding the terror scenario in Bangalore. Infosys has beefed up security to protect employees and clients.
The US FDA has said food from cloned animals is safe. Though it won't land in markets yet, cloned meat is being served at one company.
At $2.6 trillion, the Indian economy is currently ranked sixth in the world behind the US, China, Japan, Germany and the UK.
Sometimes, love and money do go hand in hand. Just ask matchmaker Samantha Daniels.
Mukesh Ambani-promoted biotech venture Reliance Life Sciences is close to acquiring a US company for nearly $1 billion (Rs 4,500 crore).
Leading biotech firm, Biocon Ltd, on Tuesday said it would invest $10 million (about Rs 45 crore) in the next 12 months to expand its facilities.
This is Tata's seventh investment this year.
Kiran Mazumdar-Shaw, chairman and managing director of Biocon, Chanda Kochar, executive director of ICICI Bank and Vidya Chhabria, chairman of Jumbo Group
The Institute of Clinical Research invites applications for its one-year, part-time Post-graduate Diploma in Clinical Research.
The company expects insulin, its other branded formulations and research services to drive growth.
An Indian Biotech Company that is testing a novel anti-cancer drug on patients in Bangalore says it is not alarmed by the London trial where the use of a similar class of drug led to disastrous results.
While the manufacturing facility would be located in the Jawahar Pharma City, a pharma special economic zone near Visakhapatnam, the R&D facility would be set up in the phase 3 biotech park near Hyderabad.
Sayre Therapeutics aims for a spot among top 5 players in oncology.
Biotech major Biocon Ltd's net profit for the quarter ended June 2004 zoomed by 112 per cent at Rs 48.6 crore as compared to Rs 22.9 crore in the first quarter of the previous fiscal.
Monopolies and Restrictive Trade Practices Commission on Thursday issued notice of enquiry against Monsanto and its fully owned Indian subsidiary Mahyco for ignoring its direction asking them to reduce the trait value of transgenic Bt cotton seeds.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries
The Supreme Court on Monday declined to stay the order passed by the Andhra Pradesh government directing the US based biotech major Monsanto to sell its geneticaly modified Bt cotton seed at the price not more than Rs 750.
Pai sought to look at the issue of founders raising questions as shareholder activism.
Reflecting the enthusiasm among private companies for setting up special economic zones, the board of approval for SEZs will consider over 100 proposals on March 17 - its first meeting since the implementation of SEZ Act and Rules last month.
Biotech firm Biocon will make equity investment in Vaccinex Inc. and said it has tied up with the US firm to discover and develop therapeutic antibody products for cancer, inflammation and autoimmune diseases.
Lady Bird Bio Beer, which was launched in the Kerala markets on Wednesday, increases bio-availability of vitamins, according to its inventor B Srinivas Amarnath of Advaith Biotech Pvt Ltd.
IndiaCo, a Pune-based equity investment firm, on Wednesday, said that it has received approval for $800,000 programme from the World Bank to improve its incubation and innovation centre and support upcoming companies in India and abroad.\n\n\n\n
Impacted by price pressure and other factors, the country's largest biotech firm, Biocon, on Wednesday reported that its net profit had plummeted 20 per cent to Rs 39 crore
Bangalore-based biotech company, Biocon is in the process of developing oral insulin for diabetes treatment.
The centre had opposed the plea, saying Asthana had an outstanding career and had supervised over 40 high-profile cases like coal scam, AugustaWestland scam, blackmoney and money laundering cases.
Bangalore-based Biocon Ltd and a US biotech firm Nobex Corporation will jointly develop an oral insulin product for the treatment of diabetes.
New Zealand Prime Minister Helen Clarke on Monday said there were immense opportunities to enhance bilateral trade with India.
Biotech major Biocon will file an application with the US Federal Drug Administration to begin clinical trials for oral insulin, which, it says, would be the world's first insulin that could be consumed orally.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances